FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component

48798 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Existential restriction modifier (core metadata concept)
Members targetComponentId
Capnocytophaga canimorsus Capnocytophaga canimorsus (organism)
Capnocytophaga canimorsus Capnocytophaga canimorsus (organism)
Caprine adenovirus Goat adenovirus
Caprine adenovirus Goat adenovirus
Capsaicin 179mg/hour transdermal patch Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug)
Capsaicin 179mg/hour transdermal patch Product containing precisely capsaicin 179 milligram/1 each conventional release cutaneous patch (clinical drug)
Capsule of distal interphalangeal joint of great toe Structure of capsule of interphalangeal joint of great toe
Capsule of distal interphalangeal joint of great toe Structure of capsule of interphalangeal joint of great toe
Captopril allergy Non-allergic hypersensitivity to captopril (finding)
Captopril allergy Non-allergic hypersensitivity to captopril (finding)
Carbachol 1% eye drops (substance) Carbachol 10 mg/mL eye solution
Carbachol 1% eye drops (substance) Carbachol 10 mg/mL eye solution
Carbachol 1.5% eye drops Carbachol 15 mg/mL eye solution
Carbachol 1.5% eye drops Carbachol 15 mg/mL eye solution
Carbachol 1.5% solution Carbachol 15 mg/mL eye solution
Carbachol 1.5% solution Carbachol 15 mg/mL eye solution
Carbachol 250micrograms/1mL injection (substance) Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug)
Carbachol 250micrograms/1mL injection (substance) Product containing precisely carbachol 250 microgram/1 milliliter conventional release solution for injection (clinical drug)
Carbamazepine 100mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 100mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 100mg m/r tablet Carbamazepine only product in oral dose form
Carbamazepine 100mg m/r tablet Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral tablet Carbamazepine only product in oral dose form
Carbamazepine 100mg prolonged-release oral tablet Carbamazepine only product in oral dose form
Carbamazepine 200mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 200mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 200mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbamazepine 200mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbamazepine 300mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 300mg m/r capsule Carbamazepine only product in oral dose form
Carbamazepine 300mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbamazepine 300mg prolonged-release oral capsule Carbamazepine only product in oral dose form
Carbenoxolone sodium 1% mouthwash granules (substance) Product containing only carbenoxolone (medicinal product)
Carbenoxolone sodium 1% mouthwash granules (substance) Product containing only carbenoxolone (medicinal product)
Carbenoxolone sodium 2% oral gel Product containing precisely carbenoxolone 20 milligram/1 gram conventional release oromucosal gel (clinical drug)
Carbenoxolone sodium 2% oral gel Product containing precisely carbenoxolone 20 milligram/1 gram conventional release oromucosal gel (clinical drug)
Carbenoxolone sodium 2% oral gel Product containing precisely carbenoxolone 20 microgram/1 milligram conventional release oral gel (clinical drug)
Carbidopa + levodopa 25mg/100mg m/r tablet Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa + levodopa 25mg/100mg m/r tablet Carbidopa 25 mg and levodopa 100 mg prolonged-release oral tablet
Carbidopa + levodopa 50mg/200mg m/r tablet Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa + levodopa 50mg/200mg m/r tablet Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 10mg/levodopa 100mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 18.75mg + levodopa 75mg + entacapone 200mg tablet Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 25mg Carbidopa anhydrous (as carbidopa) 25 mg oral tablet
Carbidopa 25mg Carbidopa anhydrous (as carbidopa) 25 mg oral tablet
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet
Carbidopa 25mg/levodopa 100mg orally disintegrating tablet Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 100 mg orodispersible tablet
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 25mg/levodopa 250mg orally disintegrating tablet Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
Carbidopa 31.25mg + levodopa 125mg + entacapone 200mg tablet Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
Carbinoxamine maleate+pseudoephedrine hydrochloride 1mg/1mL/15mg/1mL drops Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg m/r tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbinoxamine maleate+pseudoephedrine hydrochloride 8mg/120mg prolonged-release oral tablet Product containing only carbinoxamine and pseudoephedrine in oral dose form (medicinal product form)
Carbohydrate agent Carbohydrate
Carbohydrate agent Carbohydrate
Carbol fuchsin stain Carbol-fuchsin (substance)
Carbol fuchsin stain Carbol-fuchsin (substance)
Carbon-carbon lyase Carbon-carbon lyase (substance)
Carbon-carbon lyase Carbon-carbon lyase (substance)
Carbon-halide lyase Carbon-halide lyase
Carbon-halide lyase Carbon-halide lyase
Carbon-nitrogen lyase Carbon-nitrogen lyase
Carbon-nitrogen lyase Carbon-nitrogen lyase
Carbon-oxygen lyase Carbon-oxygen lyase (substance)
Carbon-oxygen lyase Carbon-oxygen lyase (substance)
Carbon-sulfur lyase Carbon-sulfur lyase
Carbon-sulfur lyase Carbon-sulfur lyase
Carboplatin 600mg/60mL infusion Antineoplastic agent (substance)
Carboplatin 600mg/60mL infusion Antineoplastic agent (substance)
Carboxy-lyase Substance with decarboxylase mechanism of action (substance)
Carboxy-lyase Substance with decarboxylase mechanism of action (substance)
Carboxylic ester hydrolase Carboxylesterase (substance)
Carboxylic ester hydrolase Carboxylesterase (substance)
Carboxylic ester hydrolase Carboxylic ester hydrolase
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe Carmellose and hydroxyapatite only product in parenteral dose form
Carboxymethylcellulose sodium + hydroxyapatite injectable implant 1mL syringe Carmellose and hydroxyapatite only product in parenteral dose form
Carboxymethylcellulose sodium 16.58% oral paste Carmellose 166 mg/g oromucosal paste
Carboxymethylcellulose sodium 16.58% oral paste Carmellose 166 mg/g oromucosal paste
Carboxymethylcellulose sodium 16.58% oral paste Product containing precisely carmellose 166 microgram/1 milligram conventional release oral paste (clinical drug)
Carbuncle of head, except face Carbuncle of head
Carbuncle of head, except face Carbuncle of head
Carbuncle of other specified site Carbuncle of skin and/or subcutaneous tissue (disorder)
Carbuncle of other specified site Carbuncle of skin and/or subcutaneous tissue (disorder)
adénome carcinoïde bronchique Carcinoid tumour of bronchus
adénome carcinoïde bronchique Carcinoid tumour of bronchus
Carcinoid bronchial adenoma Well-differentiated neuroendocrine tumor (morphologic abnormality)
Carcinoid bronchial adenoma Well-differentiated neuroendocrine tumor (morphologic abnormality)

Start Previous Page 61 of 488 Next End

Reference Sets

Reference set descriptor

Back to Start